01 September 2022>: Clinical Research
High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
Iwona Homa-Mlak 1ACDEF* , Radosław Mlak 1ACDEF , Anna Brzozowska 2BDF , Marcin Mazurek 1CEF , Tomasz Powrózek 1CDF , Monika Prendecka-Wróbel 1CEF , Aneta Szudy-Szczyrek 2ADE , Piotr Dreher 3CEF , Katarzyna Kamińska 4F , Teresa Małecka-Massalska 1ACEF , Alicja Wójcik-Załuska 5CEGDOI: 10.12659/MSM.936857
Med Sci Monit 2022; 28:e936857
Figure 3 ROC curve showing the diagnostic usefulness of irisin in detecting nutritional risk (according to the NRS scale).